SN
FLNA

Sittner & Nelson’s Filana Therapeutics FLNA Stock Holding History

Sittner & Nelson’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,800
Closed -$82.4K – 501
2024
Q3 		$82.4K Hold
2,800
– – 0.04% 196
2024
Q2 		$34.6K Buy
2,800
+2,000
+250% +$42.2K 0.02% 240
2024
Q1 		$16.2K Hold
800
– – 0.01% 301
2023
Q4 		$18K Hold
800
– – 0.01% 291
2023
Q3 		$13.3K Hold
800
– – 0.01% 315
2023
Q2 		$19.6K Hold
800
– – 0.01% 280
2023
Q1 		$19.3K Hold
800
– – 0.01% 297
2022
Q4 		$23.6K Buy
800
+400
+100% +$14.4K 0.01% 262
2022
Q3 		$17K Hold
400
– – 0.01% 283
2022
Q2 		$11K Hold
400
– – 0.01% 352
2022
Q1 		$15K Hold
400
– – 0.01% 307
2021
Q4 		$17K Hold
400
– – 0.01% 289
2021
Q3 		$25K Buy
+400
New +$33.4K 0.02% 242

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Sittner & Nelson's FLNA Position: Q4 2024 in Review

Sittner & Nelson sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 2,800 shares — an estimated $82.4K sold.

Sittner & Nelson first reported a position in FLNA in Q3 2021 and held it in 13 quarters. The position peaked at $82.4K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Sittner & Nelson reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Sittner & Nelson sold 2,800 Filana Therapeutics shares in Q4 2024, an estimated $82.4K.
  • Sittner & Nelson first reported a position in Filana Therapeutics in Q3 2021 and held it in 13 quarters.
  • Sittner & Nelson's Filana Therapeutics position peaked at $82.4K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Sittner & Nelson's 13F filing for Q4 2024, filed 11 Feb 2025.